New bioresorbable filaments for scaffolds intending local sodium alendronate release
Olivia Deretti; Guilherme Tait; Lucas Werner; Luana Engelmann; Denise Abatti Kasper Silva; Ana Paula Testa Pezzin
Abstract
Keywords
References
1 Tarafder, S., & Bose, S. (2014). Polycaprolactone-coated 3D printed tricalcium phosphate scaffolds for bone tissue engineering: in vitro alendronate release behavior and local delivery effect on in vivo osteogenesis.
2 Posadowska, U., Parizek, M., Filova, E., Wlodarczyk-Biegun, M., Kamperman, M., Bacakova, L., & Pamula, E. (2015). Injectable nanoparticle-loaded hydrogel system for local delivery of sodium alendronate.
3 Mir, M., Ahmed, N., & Rehman, A. (2017). Recent applications of PLGA based nanostructures in drug delivery.
4 Li, D., Guo, G., Deng, X., Fan, R., Guo, Q., Fan, M., Liang, J., Luo, F., & Qian, Z. (2013). PLA/PEG-PPG-PEG/Dexamethasone implant prepared by hot-melt extrusion for controlled release of immunosuppressive drug to implantable medical devices, part 2: in vivo evaluation.
5 Wang, Y., Sun, L., Mei, Z., Zhang, F., He, M., Fletcher, C., Wang, F., Yang, J., Bi, D., Jiang, Y., & Liu, P. (2020). 3D printed biodegradable implants as an individualized drug delivery system for local chemotherapy of osteosarcoma.
6 Awad, A., Fina, F., Goyanes, A., Gaisford, S., & Basit, A. W. (2021). Advances in powder bed fusion 3D printing in drug delivery and healthcare.
7 Jamróz, W., Kurek, M., Łyszczarz, E., Brniak, W., & Jachowicz, R. (2017). Printing techniques: recent developments in pharmaceutical technology.
8 Goole, J., & Amighi, K. (2016). 3D printing in pharmaceutics: a new tool for designing customized drug delivery systems.
9 Goyanes, A., Allahham, N., Trenfield, S. J., Stoyanov, E., Gaisford, S., & Basit, A. W. (2019). Direct powder extrusion 3D printing: fabrication of drug products using a novel single-step process.
10 Danda, L. J. A., Batista, L. M., Melo, V. C. S., Soares Sobrinho, J. L., & Soares, M. F. L. R. (2019). Combining amorphous solid dispersions for improved kinetic solubility of posaconazole simultaneously released from soluble PVP/VA64 and an in-soluble ammonio methacrylate copolymer.
11 Sayanjali, S., Sanguansri, L., Ying, D., Buckow, R., Gras, S., & Augustin, M. A. (2019). Extrusion of a curcuminoid-enriched oat fiber-corn-based snack product.
12 Domínguez-Robles, J., Martin, N. K., Fong, M. L., Stewart, S. A., Irwin, N. J., Rial-Hermida, M. I., Donnelly, R. F., & Larrañeta, E. (2019). Antioxidant PLA composites containing lignin for 3d printing applications: a potential material for healthcare applications.
13 Boetker, J., Water, J. J., Aho, J., Arnfast, L., Bohr, A., & Rantanen, J. (2016). Modifying release characteristics from 3D printed drug-eluting products.
14 Tyler, B., Gullotti, D., Mangraviti, A., Utsuki, T., & Brem, H. (2016). Polylactic acid (PLA) controlled delivery carriers for biomedical applications.
15 Anakabe, J., Orue, A., Huici, A. M. Z., Eceiza, A., & Arbelaiz, A. (2018). Properties of PLA/PMMA blends with high polylactide content prepared by reactive mixing in presence of poly (styrene-co-glycidyl methacrylate) copolymer.
16 Camargo, E., Serafim, B. M., Cruz, A. F., Soares, P., Oliveira, C. C., Saul, C. K., & Marino, C. E. B. (2021). Bioactive response of PMMA coating obtained by electrospinning on ISO5832-9 and Ti6Al4V biomaterials.
17 Siqueira, A. (2018).
18 Asnani, M., Vyas, K., Bhattacharya, A., Devarakonda, S., Chakraborty, S., & Mukherjee, A. K. (2009). Ab initio structure determination of anhydrous sodium alendronate from laboratory powder X-ray diffraction data.
19 Silva-Buzanello, R. A., Souza, M. F., Oliveira, D. A., Bona, E., Leimann, F. V., Cardozo, L., Fo., Araújo, P. H. H., Ferreira, S. R. S., & Gonçalves, O. H. (2016). Preparation of curcumin-loaded nanoparticles and determination of the antioxidant potential of curcumin after encapsulation.
20 Garlotta, D. (2001). A literature review of poly (lactic acid).
21 Deretti, O. (2022).
22 Cifuentes, S. C., Lieblich, M., Lopez, F. A., Benavente, F., & Gonzáles-Carrasco, J. L. (2017). Effect of Mg content on the thermal stability and mechanical behaviour of PLLA/Mg composites processed by hot extrusion.
23 Water, J. J., Bohr, A., Boetker, J., Aho, J., Sandler, N., Nielsen, H. M., & Rantanen, J. (2015). Three-dimensional printing of drug-eluting implants: preparation of an antimicrobial polylactide feedstock material.
24 Yuniarto, K., Purwanto, Y. A., Purwanto, S., Welt, B. A., Purwadaria, H. K., & Sunarti, T. C. (2016). Infrared and Raman studies on polylactide acid and polyethylene glycol-400 blend.
25 Bitencourt, S. S., Batista, K. C., Zattera, A. J., Silva, D. A. K., & Pezzin, A. P. T. (2017). Development of poly (L-lactic acid PLLA) biocomposites with waste wood.
26 Ferrández-Montero, A., Lieblich, M., Benavente, R., Gonzáles-Carrasco, J. L., & Ferrari, B. (2020). Study of the matrix-filler interface in PLA/Mg composites manufactured by material extrusion using a colloidal feedstock.
27 Oz, U. C., Küçüktürkmen, B., Devrim, B., Saka, O. M., & Bozkir, A. (2019). Development and optimization of alendronate sodium loaded PLGA nanoparticles by central composite design.
28 Wang, S., Capoen, L., D’Hooge, D. R., & Cardon, L. (2018). Can the melt flow index be used to predict the success of fused deposition modelling of commercial poly (lactic acid) filaments into 3D printed materials?
29 Silveira, E. (2015).
30 Ju, J., Peng, X., Huang, K., Li, L., Liu, X., Chitrakar, C., Chang, L., Gu, Z., & Kuang, T. (2019). High-performance porous PLLA-based scaffolds for bone tissue engineering: Preparation, characterization, and in vitro and in vivo evaluation.
31 Agüero, Á., Garcia-Sanoguera, D., Lascano, D., Rojas-Lema, S., Ivorra-Martinez, J., Fenollar, O., & Torres-Giner, S. (2020). Evaluation of different compatibilization strategies to improve the performance of injection-molded green composite pieces made of polylactide reinforced with short flaxseed fibers.
32 Huang, Y., Liu, Y., & Zhao, C. (1998). Morphology and properties of PETE/PA-6/E-44 blends.
33 Delabarde, C., Plummer, C. J. G., Bourban, P.-E., & Manson, J.-A. E. (2010). Solidification behaviour of PLLA/nHA nanocomposites.
34 Haser, A., Huang, S., Listro, T., White, D., & Zhang, F. (2017). An approach for chemical stability during melt extrusion of a drug substance with a high melting point.
35 Srivastava, A., Ahuja, R., Bhati, P., Singh, S., Chauhan, P., Vashisth, P., Kumar, A., & Bhatnagar, N. (2020). Fabrication and characterization of PLLA/Mg composite tube as the potential bioresorbable/biodegradable stent (BRS).
36 Wu, W., Zheng, Q., Guo, X., & Huang, W. (2009). The controlled-releasing drug implant based on the three-dimensional printing technology: fabrication and properties of.
37 Rosiak, P., Latanska, I., Paul, P., Sujka, W., & Kolesinska, B. (2021). Modification of alginates to modulate their physico-chemical properties and obtain biomaterials with different functional properties.
38 Tidau, M., Kwade, A., & Finke, J. H. (2019). Influence of high, disperse API load on properties along the fused-layer modeling process chain of solid dosage forms.
39 Drummer, D., Cifuentes-Cuélar, S., & Rietzel, D. (2012). Suitability of PLA/TCP for fused deposition modeling.
Facebook
Google+
Twitter
LinkedIn
Mendeley
StumbleUpon
CiteULike
Reddit
Email